BindingDB logo
myBDB logout

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
8648606 72 Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists.EBI Cambridge University Forvie Site
8691422 25 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.EBI Smithkline Beecham
 22 The development of a novel series of non-peptide tachykinin NK3 receptor selective antagonistsEBI TBA
 24 The rational development of small molecule tachykinin NK3 receptor selective antagonists - the utilisation of a dipeptide chemical library in drug designEBI TBA
19817444 45 Identification of a critical residue in the transmembrane domain 2 of tachykinin neurokinin 3 receptor affecting the dissociation kinetics and antagonism mode of osanetant (SR 142801) and piperidine-based structures.EBI F. Hoffmann-La Roche
 41 Identification and chemical synthesis of MDL 105,212, a non-peptide tachykinin antagonist with high affinity for NK1 and NK2 receptorsEBI TBA
 8 The design and synthesis of non-peptide ligands with affinity and selectivity for tachykinin receptorsEBI TBA
 13 Alternative strategies towards the identification of chemical lead compounds by rational designEBI TBA
 23 Methionine replacements in biologically active peptidesEBI TBA
10937720 24 Combined tachykinin receptor antagonist: synthesis and stereochemical structure-activity relationships of novel morpholine analogues.EBI Sankyo
1714957 12 Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.EBI Hebrew University of Jerusalem
1378901 18 The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisst.EBI Pfizer